Largest US Stock Movers — October 1, 2026
Query: top movers today · data as of 2026-10-01
Rebuilt the daily movers screen for the October 1, 2026 session: Top Gainers (25 names, sorted by 1D return descending) led by Mattel, Accenture and Synopsys, and Top Losers (25 names, sorted ascending) led by a distorted Corteva print plus a biotech- and materials-heavy decliner list. Both tables include sector/industry, 1D/1M/6M returns, market cap, relative volume, momentum potential, P/E (TTM), days since earnings and % from 52-week high, with fresh commentary on all 50 rows and a new narrative contrasting the AI supply-chain bid with binary-risk decliners.
Ranked purely on the latest single-session return, the two extremes of the US tape are sharply asymmetric. The winners are dominated by AI infrastructure — IT services and networking/optical names re-rate on contracted AI demand — with heavy relative volume confirming conviction. The decliners are a biotech- and materials-heavy list, a reminder that single-day drawdowns cluster where clinical, financing or commodity risk is binary.
Top Gainers — October 1, 2026
| Symbol | Security Name | Sector | Industry | Last Close | 1D Return | 1M Return | 6M Return | Market Cap | Relative Volume | Momentum Potential | P/E (TTM) | Days Since Earnings | % From 52W High | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAT | Mattel, Inc. | Consumer Discretionary | Leisure | 15.04 | 18.80% | 3.08% | 3.30% | 4.297e+09 | 7.3168 | 11.4 | 11.22 | 57 | -32.13% | Consumer-discretionary leisure name posting a double-digit day against a weak discretionary tape; moves of this size in a toy/entertainment company usually trace to a corporate action or takeover chatter rather than operations. Heavy volume confirms real institutional interest — watch for follow-through or a give-back if it was headline-driven rather than fundamental. |
| ACN | Accenture plc | Information Technology | Information Technology Services | 212.3 | 15.78% | 12.87% | 9.95% | 1.299e+11 | 4.4589 | 60.6 | 16.96 | 0 | -26.42% | The session's most important story: an IT services giant re-rating violently after huge quarterly bookings. The market had been pricing AI as a threat to consulting budgets; instead clients are paying integrators to make AI work. That flips the whole services complex from AI victim to AI beta. |
| SNPS | Synopsys, Inc. | Information Technology | Software - Infrastructure | 490.54 | 12.78% | 18.25% | 23.64% | 9.401e+10 | 3.2058 | 76 | 112.25 | 35 | -8.23% | Design-automation supplier riding the custom-silicon wave — every hyperscaler building its own accelerator needs EDA tooling and IP. Contracted design wins give revenue visibility that pure fab-exposed names lack, and EDA is the tightest oligopoly in semis. |
| TDAY | USA TODAY Co., Inc. | Communication Services | Publishing | 7.06 | 12.24% | 14.24% | -0.56% | 1.037e+09 | 2.9702 | 16.1 | — | 56 | -21.82% | Publishing name surging on roughly triple normal turnover — a low-float, sub-$2bn media stock where modest flow drives outsized percentage moves. Local news and print advertising economics remain structurally challenged, so this is a flow event rather than a demand inflection. |
| FICO | Fair Isaac Corporation | Information Technology | Software - Application | 661.75 | 11.69% | -40.04% | -37.69% | 1.429e+10 | 5.82 | 47 | 19.18 | 63 | -64.79% | A savage bounce from deeply negative momentum territory, with a year of drawdown behind it. The lender/credit-scoring franchise is being repriced on rate-path and consumer-credit assumptions; expect violent two-way action while the market decides whether the de-rating was overdone. |
| EFXT | Enerflex Ltd | Energy | Oil & Gas Equipment & Services | 25.44 | 11.63% | 24.95% | 28.23% | 2.948e+09 | 2.8947 | 59 | 57.82 | 56 | -10.39% | Energy services participation in the broader oil complex rally — WTI strength pulls service and equipment demand with a lag. Small-cap, lumpy order book makes it a high-beta expression of the crude move rather than a diversified energy hold. |
| COHR | Coherent Corp. | Information Technology | Scientific & Technical Instruments | 319.19 | 10.90% | 17.34% | 28.81% | 6.251e+10 | 1.7828 | 8.4 | 77.66 | 49 | -25.23% | Optical/photonics supplier to AI datacenter interconnect — the picks-and-shovels layer of the build-out. Demand here is contracted against hyperscaler capacity plans, so the move reflects real order visibility rather than sentiment, though valuation now embeds a lot of it. |
| WOLF | Wolfspeed, Inc. Common Stock New | Information Technology | Semiconductors | 31.17 | 10.81% | 18.47% | 89.48% | 1.65e+09 | 0.8899 | 2.4 | — | 42 | -57.59% | A high-risk silicon-carbide turnaround squeezed higher on low turnover — the thin liquidity cuts both ways. The story remains about balance-sheet survival and device demand recovery, so treat this as a volatility event inside a restructuring narrative, not a trend change. |
| EFOR | Everforth, Inc. | Information Technology | Information Technology Services | 36.19 | 10.00% | 19.52% | -5.93% | 1.484e+09 | 1.4898 | 32.2 | 18.65 | 63 | -32.08% | Small-cap IT services and data/AI outsourcing name riding the sector-wide services bid. Thin liquidity and a concentrated client base mean the equity is far more volatile than the larger consultants it trades alongside. |
| INOD | Innodata Inc. | Information Technology | Information Technology Services | 71.85 | 9.26% | 31.50% | 81.16% | 2.47e+09 | 1.7884 | 75.5 | 55.7 | 55 | -40.86% | Small-cap data-engineering contractor levered squarely to AI training-data demand. Revenue is growing fast but the business is customer-concentrated and the multiple reflects that optionality — a pure sentiment vehicle that can move double digits on modest flow. |
| GWRE | Guidewire Software, Inc. | Information Technology | Software - Application | 155.32 | 8.94% | -22.76% | 4.54% | 1.274e+10 | 1.1607 | 83.6 | 83.06 | 27 | -38.91% | Property-and-casualty software vendor recovering from a sharp multi-month de-rating. Insurance IT spend is sticky and long-cycle, so weakness here tends to be about multiple compression and deal-timing optics rather than lost demand. |
| LWLG | Lightwave Logic, Inc. - Common Stock | Materials | Specialty Chemicals | 5.44 | 8.80% | 6.04% | -20.47% | 8.387e+08 | 1.4472 | 49.9 | — | — | -70.14% | Early-stage electro-optic polymer developer with essentially no revenue at commercial scale — the equity is a long-dated option on a technology platform. Very low liquidity means the day's move says more about flow than about the silicon-photonics roadmap. |
| CNXC | Concentrix Corporation | Information Technology | Information Technology Services | 27.01 | 8.26% | -16.33% | 4.76% | 1.646e+09 | 1.3732 | 13.7 | — | 1 | -44.03% | Customer-experience outsourcer catching the same services-sector bid as the sector leader — a sympathy move rather than company-specific news. Levered balance sheet and AI-displacement debate make it a much lower-quality version of the same trade. |
| BLMN | Bloomin' Brands, Inc. | Consumer Discretionary | Restaurants | 8.38 | 8.13% | -13.96% | 52.92% | 7.175e+08 | 3.0378 | 59.5 | 26.19 | 57 | -29.28% | Casual-dining operator bouncing hard with turnover roughly triple normal, likely on activist or restructuring speculation. Restaurant margins are under pressure from labor and traffic, so any move here is a capital-structure story rather than a same-store-sales one. |
| AAOI | Applied Optoelectronics, Inc. | Information Technology | Communication Equipment | 107.32 | 8.12% | 3.80% | 24.28% | 9.112e+09 | 1.201 | 5.4 | — | 55 | -51.90% | Optical transceiver supplier levered to AI datacenter bandwidth, and one of the few names still well below its high despite the industry's run — the market is discounting execution and balance-sheet history rather than end-market demand. |
| CRDO | Credo Technology Group Holding | Information Technology | Semiconductors | 210.17 | 7.90% | 1.71% | 119.11% | 3.95e+10 | 1.3755 | 98.9 | 83.73 | 29 | -30.53% | High-growth AI connectivity supplier for active electrical cables in datacenter racks. Revenue is compounding at triple-digit rates off a small base; the equity behaves as a pure derivative of hyperscaler capex expectations, so position sizing matters more than direction. |
| CIEN | Ciena Corporation | Information Technology | Communication Equipment | 379.14 | 7.77% | 5.22% | -8.73% | 5.377e+10 | 1.1182 | 49 | 126.38 | 28 | -39.53% | Optical networking equipment vendor at the other end of the same AI bandwidth build-out. Carriers and cloud operators are re-tooling for AI-driven traffic, which is why the networking equipment complex moves as a bloc rather than on individual prints. |
| LITE | Lumentum Holdings Inc. | Information Technology | Communication Equipment | 1,046 | 7.67% | 20.35% | 36.77% | 9.381e+10 | 1.5862 | 98.8 | — | 50 | -0.69% | Sitting essentially at its 52-week high — the only name on this list near highs, which tells you where the durable money is being made. Optical components are in genuine shortage relative to AI interconnect demand. |
| KD | Kyndryl Holdings, Inc. | Information Technology | Information Technology Services | 12.12 | 7.64% | -7.62% | -5.68% | 2.64e+09 | 2.59 | 14.3 | 32.76 | 57 | -60.43% | Managed-infrastructure provider lifted by the sector-wide services re-rating. The bull case rests on AI datacenter modernization work; the bear case is that the business is structurally lower-margin than the consultants it trades alongside. |
| STLA | Stellantis N.V. | Consumer Discretionary | Auto Manufacturers | 4.69 | 7.57% | -12.34% | -36.88% | 1.837e+10 | 2.3704 | 17.7 | — | 63 | -61.30% | Beaten-down automaker up sharply off a depressed base as tariff and EV-transition headwinds get re-examined. Volume is elevated but the stock is still far below its high — a deep-value bounce that needs evidence of North American margin stabilization to hold. |
| ORN | Orion Group Holdings, Inc. | Industrials | Engineering & Construction | 9.19 | 7.49% | 1.55% | -18.24% | 3.722e+08 | 1.538 | 33.8 | 114.87 | 64 | -46.38% | Micro-cap marine construction and specialty contracting firm; moves of this size are typically project-award or backlog headlines amplified by a tiny float. Infrastructure spending is a real tailwind, but lumpy contract timing makes results extremely volatile. |
| DXC | DXC Technology Company | Information Technology | Information Technology Services | 11.64 | 7.48% | 4.30% | -7.18% | 1.86e+09 | 1.3071 | 29.2 | 15.73 | 62 | -24.56% | Legacy IT outsourcing provider that failed to re-rate with the services complex and now trades at a deep discount to peers. The bid looks like a value/sympathy rotation into a business whose revenue base is in secular decline — a trade on cheapness, not growth. |
| UI | Ubiquiti Inc. | Information Technology | Communication Equipment | 609.64 | 7.42% | 3.90% | -25.83% | 3.69e+10 | 0.8381 | 87.6 | 39.15 | 41 | -43.79% | Enterprise networking and wireless hardware name hitting a strong day on light turnover — thin float and low liquidity amplify headline moves. Niche franchise, high price per share, and limited sell-side coverage make it news-driven rather than flow-driven. |
| HURN | Huron Consulting Group Inc. | Industrials | Consulting Services | 168.42 | 7.39% | 6.96% | 31.34% | 2.68e+09 | 2.1278 | 73.2 | 25.36 | 64 | -9.25% | Consulting firm with a healthcare and higher-education practice mix, participating in the broad services strength. Its revenue is largely project-based and lumpy, so the move is more sector sympathy than evidence of a bookings acceleration. |
| APPN | Appian Corporation | Information Technology | Software - Infrastructure | 37.77 | 7.09% | -6.49% | 57.05% | 2.705e+09 | 1.0203 | 93.3 | — | 56 | -17.24% | Low-code automation vendor that has been a high-multiple AI-adjacent software name. Moves like this tend to be sentiment and positioning rather than fundamentals — the company's path to durable profitability remains the key debate. |
Top Losers — October 1, 2026
| Symbol | Security Name | Sector | Industry | Last Close | 1D Return | 1M Return | 6M Return | Market Cap | Relative Volume | Momentum Potential | P/E (TTM) | Days Since Earnings | % From 52W High | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTVA | Corteva, Inc. | Materials | Agricultural Inputs | 12.57 | -83.81% | -85.67% | -84.94% | 8.387e+09 | 14.8753 | 9.6 | 7.62 | 62 | -86.11% | A print this extreme against a multi-billion-dollar seed and crop-chemicals franchise is almost certainly a corporate-action artifact — split adjustment or a fundamental restatement — rather than a real one-day collapse in enterprise value. Treat the quoted change as unreliable until the price history normalizes; flag for data review. |
| NKTR | Nektar Therapeutics - Common Stock | Health Care | Biotechnology | 46.99 | -22.39% | -34.51% | -37.93% | 1.604e+09 | 6.3387 | 13.2 | — | 48 | -53.17% | Clinical-stage biotech unwinding after a run, with elevated turnover. This sector trades on trial readouts and financing windows, so single-day drawdowns reflect binary risk being repriced rather than a change in commercial standing. |
| ACRS | Aclaris Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 4.41 | -16.16% | -26.74% | 6.52% | 6.491e+08 | 2.3279 | 37 | — | 56 | -32.52% | Micro-cap clinical-stage dermatology biotech with a shallow pipeline and no commercial revenue — acutely sensitive to financing and trial headlines, where outcomes are binary rather than gradual. |
| SGML | Sigma Lithium Corporation | Materials | Other Industrial Metals & Mining | 8.335 | -11.33% | -32.01% | -29.54% | 1.53e+09 | 3.157 | 8.7 | — | 48 | -64.76% | Lithium developer hit by the ongoing battery-metals bear market — lithium prices and permitting timelines drive the equity far more than company execution. Development-stage miners in this space need capital precisely when capital is hardest to raise. |
| UMAC | Unusual Machines, Inc. Common Stock | Information Technology | Computer Hardware | 21.78 | -11.03% | -3.84% | 76.50% | 1.088e+09 | 1.4897 | 35.8 | — | 56 | -36.05% | Small-cap drone and unmanned-systems component maker that had more than doubled over six months on defense and homeland-security enthusiasm. The equity trades well ahead of its revenue base, so any cooling of the drone narrative or dilution news produces outsized downside. |
| NBTX | Nanobiotix S.A. | Health Care | Biotechnology | 27.9 | -10.46% | -28.99% | -6.84% | 1.842e+09 | 1.3018 | 49.6 | — | 2 | -49.34% | French nanomedicine developer whose US listing layers dilution and headline risk on top of clinical risk. A data- and partnership-dependent story, so sector-wide rare-disease de-rating compounds any company-specific doubt. |
| ITG | ITG, Inc. | Industrials | Engineering & Construction | 7.015 | -9.83% | -41.49% | — | 8.685e+08 | 0.9951 | — | — | 49 | -60.39% | Small engineering and construction firm with a short trading history and no fundamentals coverage in the dataset, leaving the decline without a valuation anchor. Project-based revenue and a tiny float make it prone to sharp headline-driven swings. |
| PSKY | Paramount Skydance Corporation | Communication Services | Entertainment | 9.34 | -9.58% | -11.06% | 1.93% | 1.048e+10 | 2.7401 | 23 | — | 57 | -51.18% | Media conglomerate under sustained pressure as the streaming consolidation story gets repriced. Advertising softness and integration costs from the merger dominate the narrative; the equity is now a restructuring and credibility story. |
| ANGX | Angel Studios, Inc. Class A Common Stock | Communication Services | Entertainment | 4.23 | -9.42% | -2.53% | 41.00% | 7.9e+08 | 1.584 | 22.5 | — | 57 | -54.61% | Early-stage entertainment studio that had run hard on retail enthusiasm around its content slate. A crowdfunded, fan-driven shareholder base is unusually reactive, so drawdowns from promotion-driven highs tend to extend. |
| SHAZ | SharonAI Holdings, Inc. - Class A Common Stock | Information Technology | Information Technology Services | 49.85 | -8.70% | -5.30% | 80.49% | 1.785e+09 | 1.193 | 48.5 | — | 55 | -46.22% | AI datacenter build-out name selling off hard — a reminder that within the AI complex, balance-sheet-weak and unproven operators get punished even while the equipment suppliers thrive. The market is increasingly discriminating between contracted backlog and narrative. |
| NMAX | Newsmax, Inc. | Communication Services | Broadcasting | 9.87 | -8.70% | -5.00% | 79.45% | 1.275e+09 | 1.2822 | 31.3 | 58.06 | 48 | -24.31% | Small-cap industrial machinery name tied to European manufacturing and cleantech capex. Lumpy order intake and a narrow customer base mean one project delay moves the equity; the weakness tracks euro-area industrial softness more than company news. |
| SHMD | SCHMID Group N.V. | Industrials | Specialty Industrial Machinery | 4.445 | -8.54% | 42.93% | -18.89% | 3.78e+08 | 1.509 | 11.1 | — | 37 | -57.34% | Recently listed specialty pharmaceutical name where the drop looks like early-holder rotation rather than a fundamental reset. New listings lack price history and analyst coverage, widening the range of explanations for any single session. |
| PRGS | Progress Software Corporation | Information Technology | Software - Infrastructure | 36.58 | -8.48% | -19.11% | 45.80% | 1.495e+09 | 3.5227 | 92.2 | 17.76 | 0 | -21.95% | Infrastructure software vendor that had been one of the year's better software performers before this drop — the reversal of a crowded winner rather than a broken business. Its maintenance-heavy revenue base makes it a target of the AI-displacement debate, which is enough to trigger de-rating when positioning is stretched. |
| GRND | Grindr Inc. | Information Technology | Software - Application | 14.17 | -8.17% | -8.76% | 18.58% | 2.463e+09 | 3.0056 | 95.4 | 30.15 | 55 | -21.01% | Dating app declining alongside a broad de-rating of consumer internet subscriptions. Growth in the core app is maturing, making any monetization or ad-product misstep disproportionately punishing for a momentum-sensitive shareholder base. |
| GENB | Generate Biomedicines, Inc. - Common Stock | Health Care | Biotechnology | 13.8 | -8.12% | -12.60% | 3.68% | 1.771e+09 | 1.3506 | — | — | 56 | -32.29% | Clinical-stage company with no revenue and no valuation anchor in the dataset — the decline reprices pipeline and financing risk rather than a commercial development, leaving the equity event-driven until first data reads out. |
| ODTX | Odyssey Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 20.42 | -8.10% | -16.65% | — | 9.814e+08 | 1.1305 | — | — | 56 | -29.00% | Clinical-stage company with no commercial revenue and no valuation anchor in the dataset, leaving the stock hostage to trial timelines and cash runway. Moves of this size are usually financing-related or sector-wide de-risking rather than a change in the science. |
| SLS | SELLAS Life Sciences Group, Inc. - Common Stock | Health Care | Biotechnology | 11.33 | -7.96% | -14.30% | 169.12% | 2.288e+09 | 0.921 | 88 | — | 50 | -26.71% | Micro-cap paper and specialty chemicals producer exposed to cyclical pulp and cellulose pricing. A sub-$500m market cap with limited float means a modest shift in commodity sentiment becomes a large percentage move. |
| RYAM | Rayonier Advanced Materials Inc | Materials | Chemicals | 7.34 | -7.90% | -11.88% | -34.11% | 4.965e+08 | 2.1649 | 1.4 | — | 57 | -37.53% | Clinical-stage oncology developer whose option value is concentrated in a handful of programs. Index-level biotech risk appetite, not company news, often explains sessions like this. |
| EIKN | Eikon Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 7.41 | -7.84% | -31.89% | -26.49% | 4.014e+08 | 1.2879 | 30.4 | — | 48 | -54.43% | Early-stage therapeutics company with a short public history and no revenue — the move reflects the broad biotech risk-off and financing-window anxiety rather than a specific clinical event. Low float and sparse coverage amplify the percentage swings. |
| RGEN | Repligen Corporation | Health Care | Medical Instruments & Supplies | 177.23 | -7.80% | 4.24% | 58.96% | 1e+10 | 1.7914 | 72.3 | — | 65 | -8.91% | Life-science tools maker caught in the pullback of that whole complex despite a strong longer-run trend — a rare high-quality name in this decliner list. Bioprocessing demand is tied to pharma R&D budgets, so weakness here is more about valuation and rotation than end-market erosion. |
| VRDN | Viridian Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 18.99 | -7.77% | -17.54% | -0.84% | 2.151e+09 | 2.0016 | 25.4 | — | 56 | -43.78% | Clinical-stage biotech with heavy turnover after a multi-month slide. Single-program pipelines make financing capacity the binding constraint — sentiment flips fast when cash runway becomes the question. |
| ACCV | Accelevation Holdings Corp. - Class A ordinary shares | Industrials | Electrical Equipment & Parts | 16.585 | -7.63% | — | — | 3.709e+09 | 0.8041 | — | — | — | -7.63% | Recently listed electrical equipment maker near its 52-week high with essentially no fundamentals coverage — the pullback reads as post-IPO profit-taking in a low-float name rather than a change in industrial demand. |
| MLCO | Melco Resorts & Entertainment L | Consumer Discretionary | Resorts & Casinos | 4.14 | -7.59% | -18.34% | -28.25% | 1.574e+09 | 1.8567 | 45.9 | 7.02 | 49 | -55.91% | Asian casino operator with Macau and Philippines exposure — the equity tracks Chinese consumer travel, visa policy and gaming-revenue trends far more than company execution. A high-beta proxy for China consumer sentiment. |
| LQDA | Liquidia Corporation | Health Care | Drug Manufacturers - Specialty & Generic | 27.99 | -7.50% | -58.17% | -25.30% | 2.505e+09 | 10.3434 | 44.4 | 19.99 | 50 | -69.25% | Specialty pharma name decimated over the past month on top of today's decline, with exceptionally heavy volume — the signature of a regulatory or competitive setback rather than ordinary selling. Specialty drug launches carry binary reimbursement and label risk. |
| CAI | Caris Life Sciences, Inc. | Health Care | Biotechnology | 28.35 | -7.44% | 14.41% | 48.20% | 8.014e+09 | 0.8869 | 94.6 | 2.96 | 216 | -13.96% | Recently public diagnostics company giving back gains on light volume. Small-cap diagnostics names with short trading histories swing widely on limited float and early commercial data points; the low turnover suggests profit-taking rather than a fundamental event. |
0
Two Different Markets on the Same Day
The single-session extremes on this screen read as a rotation statement rather than a risk statement.
The winning side is a supply chain, not a theme. Information Technology accounts for the overwhelming majority of the largest gainers, and within it the composition is telling: IT services (Accenture, Everforth, Innodata, Concentrix, Kyndryl, DXC), optical networking and interconnect (Coherent, Applied Optoelectronics, Credo, Ciena, Lumentum, Ubiquiti), design software (Synopsys) and semis (Wolfspeed, Credo). This is the equipment-and-integration layer of the AI build-out, and the services names in particular are being repriced on the realization that enterprises cannot implement AI without paying integrators. Heavy relative volume across the group — several names trading 2-5x normal — distinguishes this from a low-conviction drift.
The losing side is where the risk is binary. Health Care dominates the decliner list, and specifically clinical-stage biotechnology, where value is contingent on trial readouts and financing windows — exactly the kind of asset that gets sold first when capital is scarce. Materials, lithium and battery-metals developers, media and a recently-listed diagnostics name round out the list. There are almost no large, profitable franchises among the losers, which is itself the signal: this is a market penalizing optionality and funding risk, not one indiscriminately de-risking.
How to read the extremes. First, single-day rankings are liquidity events as much as fundamental ones — several gainers are sub-$3bn names where modest flow produces double-digit percentage moves. Second, watch the clustering: when a whole industry group (IT services, optical networking) appears repeatedly in one table, the move is about the group's demand narrative, not about any one print. Third, note the asymmetry in quality — the gainers include genuine contracted-revenue businesses, while the decliners skew toward names that require capital markets to stay open.
The practical takeaway is that breadth remains narrow and the market is paying for supply-constrained AI infrastructure and shunning duration- and funding-dependent exposure. Extending these moves into next week requires either follow-through earnings confirmation or continued sector-wide flow — without one of the two, single-day extremes of this magnitude frequently mean-revert.
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.